KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Shares Issued (2018 - 2025)

Vir Biotechnology's Shares Issued history spans 8 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 10.42% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $2.8 million, down 25.67%, while the annual FY2025 figure was $2.8 million, 25.67% down from the prior year.
  • Shares Issued for Q4 2025 was $1.0 million at Vir Biotechnology, up from $510000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $3.7 million in Q3 2021 and bottomed at -$380000.0 in Q4 2022.
  • The 5-year median for Shares Issued is $1.0 million (2025), against an average of $1.4 million.
  • The largest annual shift saw Shares Issued surged 1544.76% in 2021 before it plummeted 111.04% in 2022.
  • A 5-year view of Shares Issued shows it stood at $3.4 million in 2021, then plummeted by 111.04% to -$380000.0 in 2022, then skyrocketed by 123.42% to $89000.0 in 2023, then soared by 1204.49% to $1.2 million in 2024, then dropped by 10.42% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Shares Issued are $1.0 million (Q4 2025), $510000.0 (Q3 2025), and $649000.0 (Q2 2025).